Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q80X82

Entry ID Method Resolution Chain Position Source
AF-Q80X82-F1 Predicted AlphaFoldDB

47 variants for Q80X82

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3397821641 3 S>I No EVA
rs3388867776 12 R>L No EVA
rs3388886551 30 M>I No EVA
rs3388886499 66 D>E No EVA
rs3388863670 85 S>F No EVA
rs3388881564 171 L>I No EVA
rs3388883941 172 L>W No EVA
rs3397263435 182 H>D No EVA
rs3397625086 182 H>Q No EVA
rs3397711444 185 K>E No EVA
rs242637735 236 V>L No EVA
rs3397586284 332 Q>* No EVA
rs3396883907 332 Q>P No EVA
rs3388886485 353 T>I No EVA
rs3388872159 471 Q>E No EVA
rs3388880160 536 G>S No EVA
rs3388886865 554 T>K No EVA
rs3388858752 558 V>M No EVA
rs3388858804 591 S>N No EVA
rs3388880176 598 S>P No EVA
rs3388881647 659 Q>* No EVA
rs3388858812 686 C>* No EVA
rs3388885072 721 S>N No EVA
rs3388890172 744 Q>E No EVA
rs3388883971 748 Y>H No EVA
rs3388883940 752 F>S No EVA
rs3388886928 768 V>M No EVA
rs3412824827 805 I>M No EVA
rs3388875455 823 V>M No EVA
rs3388890156 829 Q>E No EVA
rs3388881579 831 I>F No EVA
rs3411747127 832 R>L No EVA
rs3388863677 835 G>D No EVA
rs3388883883 849 P>L No EVA
rs3388886488 880 L>V No EVA
rs3388876292 938 S>F No EVA
rs3388881582 942 P>S No EVA
rs3388867763 996 M>K No EVA
rs3388881632 1005 S>T No EVA
rs3388872166 1013 G>E No EVA
rs3397724017 1015 F>I No EVA
rs3397626352 1015 F>L No EVA
rs3388875464 1021 A>S No EVA
rs263068246 1205 V>I No EVA
rs246216032 1267 A>T No EVA
rs6211046 1271 A>T No EVA
rs3397626392 1281 E>D No EVA

No associated diseases with Q80X82

2 regional properties for Q80X82

Type Name Position InterPro Accession
domain Symplekin C-terminal 887 - 1068 IPR022075
domain Symplekin/Pta1, N-terminal 123 - 344 IPR032460

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm, cytoskeleton
  • Cell junction, tight junction
  • Cell membrane ; Peripheral membrane protein ; Cytoplasmic side
  • Cell junction
  • Nucleus, nucleoplasm
  • Cytoplasmic face of adhesion plaques (major) and nucleoplasm (minor) (in cells with TJ)
  • Nucleoplasm (in cells without TJ)
  • Nuclear bodies of heat-stressed cells
  • Colocalizes with HSF1 in nuclear stress bodies upon heat shock
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
bicellular tight junction An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoskeleton A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
mRNA cleavage and polyadenylation specificity factor complex A multisubunit complex that binds to the canonical AAUAAA hexamer and to U-rich upstream sequence elements on the pre-mRNA, thereby stimulating the otherwise weakly active and nonspecific polymerase to elongate efficiently RNAs containing a poly(A) signal.
nuclear body Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
nuclear stress granule A dense aggregation in the nucleus composed of proteins and RNAs that appear when the cell is under stress.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

4 GO annotations of biological process

Name Definition
cell adhesion The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
mRNA polyadenylation The enzymatic addition of a sequence of 40-200 adenylyl residues at the 3' end of a eukaryotic mRNA primary transcript.
negative regulation of protein binding Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
positive regulation of protein dephosphorylation Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q92797 SYMPK Symplekin Homo sapiens (Human) PR
10 20 30 40 50 60
MASSSGDSVT RRSVASQFFT QEEGPSIDGM TTSERVVDLL NQAALITNDS KITVLKQVQE
70 80 90 100 110 120
LIINKDPTLL DNFLDEIIAF QADKSIEVRK FVIGFIEEAC KRDIELLLKL IANLNMLLRD
130 140 150 160 170 180
ENVNVVKKAI LTMTQLYKVA LQWMVKSRVI SDLQEACWDM VSSMAGEIIL LLDSDNDGIR
190 200 210 220 230 240
THAIKFVEGL IVTLSPRMAD SEVPRRQEHD ISLDRIPRDH PYIQYNVLWE EGKAAVEQLL
250 260 270 280 290 300
KFMVHPAISS INLTTALGSL ANIARQRPMF MSEVIQAYET LHANLPPTLA KSQVSSVRKN
310 320 330 340 350 360
LKLHLLSVLK HPASLEFQAQ ITTLLVDLGT PQAEIARNMP SSKDSRKRPR DDTDSTLKKM
370 380 390 400 410 420
KLEPNLGEDD EDKDLEPGPS GTSKASAQIS GQSDTDITAE FLQPLLTPDN VANLVLISMV
430 440 450 460 470 480
YLPETMPASF QAIYTPVESA GTEAQIKHLA RLMATQMTAA GLGPGVEQTK QCKEEPKEEK
490 500 510 520 530 540
VVKPESVLIK RRLSVQGQAI SVVGSQSTMS PLEEEVPQAK RRPEPIIPVT QPRLAGAGGR
550 560 570 580 590 600
KKIFRLSDVL KPLTDAQVEA MKLGAVKRIL RAEKAVACSG AAQVRIKILA SLVTQFDSGF
610 620 630 640 650 660
KAEVLSFILE DVRARLDLAF AWLYQEYNAY LAAGTSGTLD KYEDCLICLL SGLQEKPDQK
670 680 690 700 710 720
DGIFTKVVLE APLITESALE VIRKYCEDES RAYLGMSTLG DLIFKRPSRQ FQYLHVLLDL
730 740 750 760 770 780
SSHEKDRVRS QALLFIKRMY EKEQLREYVE KFALNYLQLL VHPNPPSVLF GADKDTEVAA
790 800 810 820 830 840
PWTEETVKQC LYLYLALLPQ NHKLIHELAA VYTEAIADIK RTVLRVIEQP IRGMGMNSPE
850 860 870 880 890 900
LLLLVENCPK GAETLVTRCL HSLTDKVPPS PELVKRVRDL YHKRLPDVRF LIPVLNGLEK
910 920 930 940 950 960
KEVIQALPKL IKLNPIVVKE VFNRLLGTQH GEGNSALSPL NPGELLIALH NIDSVKCDMK
970 980 990 1000 1010 1020
SIIKATNLCF AERNVYTSEV LAVVMQQLME QSPLPMLLMR TVIQSLTMYP RLGGFVMNIL
1030 1040 1050 1060 1070 1080
ARLIMKQVWK YPKVWEGFIK CCQRTKPQSF QVILQLPPQQ LGAVFDKCPE LREPLLAHVR
1090 1100 1110 1120 1130 1140
SFTPHQQAHI PNSIMTILEA TGKQEPEVKE APSGPLEEDD LEPLALALAP APAPAPAPAP
1150 1160 1170 1180 1190 1200
APAPAPRPPQ DLIGLRLAQE KALKRQLEEE QKQKPTGIGA PAACVSSTPS VPAAARAGPT
1210 1220 1230 1240 1250 1260
PAEEVMEYRE EGPECETPAI FISMDDDSGL AETTLLDSSL EGPLPKEAAA VGSSSKDERS
1270 1280
PQNLSHAVEE ALKTSSPETR EPESKGNS